tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LPCN Stock Latest News

Lipocine’s LPCN 2401 shows positive Phase 2 results in obesity trial
The FlyLipocine’s LPCN 2401 shows positive Phase 2 results in obesity trial
12d ago
LPCN
Lipocine’s LPCN 1148 shows positive results in Phase 2 cirrhosis study
PremiumThe Fly
Lipocine’s LPCN 1148 shows positive results in Phase 2 cirrhosis study
26d ago
LPCN
Lipocine announces first cohort dosed in LPCN 1154
PremiumThe Fly
Lipocine announces first cohort dosed in LPCN 1154
29d ago
LPCN
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
PremiumPress Releases
Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
2M ago
LPCN
Lipocine Inc (LPCN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Lipocine Inc (LPCN) Q4 Earnings Cheat Sheet
2M ago
LPCN
Lipocine Announces Key Study Dosing for Postpartum Depression Treatment
PremiumCompany AnnouncementsLipocine Announces Key Study Dosing for Postpartum Depression Treatment
2M ago
8K
LPCN
Lipocine confirms dosing regimen for pivotal study of LPCN 1154
PremiumThe Fly
Lipocine confirms dosing regimen for pivotal study of LPCN 1154
3M ago
LPCN
Lipocine to continue commercialization of Tlando through Verity Pharma
PremiumThe Fly
Lipocine to continue commercialization of Tlando through Verity Pharma
3M ago
LPCN
Lipocine Strikes Major Deal for TLANDO Franchise Rights
PremiumMarket News
Lipocine Strikes Major Deal for TLANDO Franchise Rights
3M ago
8K
LPCN
Lipocine announces license agreement for TLANDO in the U.S.
PremiumThe Fly
Lipocine announces license agreement for TLANDO in the U.S.
3M ago
LPCN
Lipocine files $150M mixed securities shelf
PremiumThe Fly
Lipocine files $150M mixed securities shelf
5M ago
LPCN
Lipocine releases late breaking presentation on LPCN 1148 Phase 2 results
PremiumThe Fly
Lipocine releases late breaking presentation on LPCN 1148 Phase 2 results
5M ago
LPCN
Lipocine price target lowered to $33 from $36 at Ladenburg
PremiumThe FlyLipocine price target lowered to $33 from $36 at Ladenburg
6M ago
LPCN
Lipocine reports Q3 EPS ($1.27), consensus (60c)
PremiumThe Fly
Lipocine reports Q3 EPS ($1.27), consensus (60c)
6M ago
LPCN
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023
PremiumPress Releases
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023
6M ago
LPCN
LPCN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LPCN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
LPCN
Lipocine and FDA agree on acceptance criteria for pivotal study of LPCN 1154
PremiumThe Fly
Lipocine and FDA agree on acceptance criteria for pivotal study of LPCN 1154
6M ago
LPCN
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2023
PremiumPress Releases
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2023
9M ago
LPCN
Lipocine reports Q2 EPS (68c), consensus (64c)
PremiumThe Fly
Lipocine reports Q2 EPS (68c), consensus (64c)
9M ago
LPCN
Is LPCN a Buy, Before Earnings?
PremiumPre-EarningsIs LPCN a Buy, Before Earnings?
9M ago
LPCN
Lipocine’s Phase 2 LPCN 1148 study results ‘compelling,’ says Cantor Fitzgerald
PremiumThe Fly
Lipocine’s Phase 2 LPCN 1148 study results ‘compelling,’ says Cantor Fitzgerald
9M ago
LPCN
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2023
PremiumPress Releases
Lipocine Announces Financial Results for the First Quarter Ended March 31, 2023
12M ago
LPCN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >